Abstract: Systems and methods of the present disclosure enable improved seizure detection and/or prediction using a seizure monitoring system. The system receives a data stream including wearable sensor data associated with a user, where the data stream includes electrodermal activity data and where the electrodermal activity data includes circadian rhythm-dependent amplitudes. The system receives a time associated with a seizure of the user. The system trains seizure machine learning model to identify a pre-ictal period associated with a time segment based on the circadian rhythm dependent amplitudes and the time associated with the seizure. The system deploys the seizure machine learning model to ingest a new data stream. Based on the new data stream, the seizure machine learning model predicts a seizure likelihood in a prediction period.

Abstract: Provided herein are agents that inhibit the function (e.g., the ability to repress Tsp-1) of Protease, Serine 2 (PRSS2) by inhibiting the binding of PRSS2 to LRP1. Further provided herein are agents that bind to binding domain I of LRP1 and mimic the activity of prosaposin in stimulating Tsp-1 Methods of using these agents in treating cancer are also provided.

Abstract: Methods for preparing and using collagen extracts and collagen scaffolds are provided. Additionally methods and related kits for the repair of articular tissue using the collagen material are provided.

Abstract: Surgical simulation devices including surgical models of various anatomical malformations as well as their methods of use and manufacture are described. In some embodiments, a surgical simulation device includes a base, a surgical model that simulates an anorectal malformation, and a model support. The model support is an internal volume sized and shaped to receive at least a portion of the surgical model such that an operating surface of the surgical model is exposed. The model support is releasably engaged with the base. In other embodiments, surgical models with simulated tissues including tissue reinforcement are described.

Abstract: Surgical simulation devices including surgical models of various anatomical malformations as well as their methods of use and manufacture are described. In some embodiments, a surgical simulation device includes a base, a surgical model that simulates an anorectal malformation, and a model support. The model support is an internal volume sized and shaped to receive at least a portion of the surgical model such that an operating surface of the surgical model is exposed. The model support is releasably engaged with the base. In other embodiments, surgical models with simulated tissues including tissue reinforcement are described.

Abstract: Systems and methods of the present disclosure determine whether the patient experiences a grand tonic clonic seizures using video recordings or sensor data or both. The systems and methods receive data from a device that continuously records video and/or sensor data, continuously analyzes the data with a processing unit utilizing machine learning to classify segments of the data as seizure or no seizure, and to classify seizure types. An alarm is produced using an output unit when an epileptic data segment is detected. The processing unit thus provides continuous and in real-time monitoring of an epilepsy patient in the home or hospital setting, e.g. while the patient is sleeping in bed. In case a seizure is detected, an alarm may inform caregivers or clinicians to help them intervene and limit the complications of this seizure for the patient.

Abstract: Methods for preparing and using collagen extracts and collagen scaffolds are provided. Additionally, methods and related kits for the repair of articular tissue using the collagen material are provided.

Abstract: An engineering workflow for prospective design of heart valve leaflet grafts for surgical heart valve reconstruction is disclosed. The engineering workflow includes utilizing a quantitative description of one or more mechanical properties of one or more materials to be used for the heart valve reconstruction to prescribe a size and/or a shape of the materials to achieve a predetermined configuration of a final reconstructed heart valve in its physiological working state for a given patient.

Abstract: Provided herein are anti-Notch4 antibodies or antigen binding fragments thereof and their use in the treatment of a disease or disorder associated with increased levels of Notch4.

Abstract: The instant invention provides methods and compositions related to discovery of Free Fatty Acid Receptor 1 (FFA1) as a therapeutic target for treatment or prevention of diseases or disorders of neurons that are characterized by angiogenesis, or of vascular diseases of the eye, retinal degeneration and/or tumors more generally. Therapeutic and/or prophylactic uses and compositions of known FFA1 inhibitors, including small molecules and nucleic acid agents, are described. Methods for identification of novel FFA1 inhibitors are also provided.

Abstract: Provided herein are methods and compositions for increasing fetal hemoglobin levels in a cell by disrupting BCL11A expression at the genomic level. Also provided herein are methods and compositions relating to the treatment of hemoglobinopathies by reinduction of fetal hemoglobin levels.

Abstract: The present invention features adeno-associated virus (AAV) vectors, compositions thereof, and methods of use thereof for transducing neurons with injured axons.

Abstract: Methods and devices for approximating jaw and corresponding tissue segments are disclosed herein. In some embodiments, the approximation device includes a first jaw attachable to a first jaw segment, a second jaw attachable to a second jaw segment, the second jaw segment being smaller than the first jaw segment, and a housing. The second jaw is movably attached to the housing, the second jaw configured to move the second jaw segment toward the first jaw segment. The second jaw is configured to translate between a first position and a second position during a first segment of travel of the second jaw, and configured to at least rotate between the second position and a third position during a second segment of travel.

Abstract: Provided herein are compositions comprising macromolecular photocleavable prodrug compounds of Formula (I), and pharmaceutically acceptable salts, co-crystals, tautomers, stereoisomers, solvates, hydrates, polymorphs, and isotopically enriched derivatives thereof. Also provided are methods, uses, pharmaceutical compositions, and kits involving the inventive compounds or compositions for treating and/or preventing a disease and/or condition (e.g., inflammatory disease, infectious disease, pain) in a subject, optionally comprising illumination of the compound, composition, or pharmaceutical composition with light of an absorption wavelength sufficient to cleave the bonds between each instance of L and each instance of X upon illumination with the light (e.g., light between approximately 200 nm to 500 nm).

Abstract: Methods for developing disease-related nanobodies and related products and kits are provided. The disease-specific proteins are extracellular matrix (ECM) proteins, domains or epitopes that are associated with various aspects of disease and are not present, or are present in very low quantities, in non-diseased individuals. Highly effective nanobodies capable of specifically binding to these ECM protein epitopes useful in in vivo imaging assays, the detection, diagnosis and treatment of diseases as well as monitoring therapeutic progress in a patient with a disease are provided herein.

Abstract: Provided herein are compositions and methods for reducing neuroinflammation and treating neurodegenerative diseases using proteinase inhibitors. The invention also provides methods for reducing post-injury scar formation in the central nervous system.

Abstract: The present invention relates in part to the discovery of genes that are deregulated in cancer stem cells (e.g., melanoma stem cells). In some aspects, methods for treating individuals having melanoma are provided; the methods involve modulating (e.g., inducing, inhibiting, etc.) the activity of the cancer stem cell associated genes. In other aspects, cell surface genes that are upregulated in melanoma stem cells are targeted for the selective isolation, detection, and killing of cancer stem cells in melanoma. Other aspects of the invention relate to reagents, arrays, compositions, and kits that are useful for diagnosing and treating melanoma.

Abstract: Provided herein are materials and methods for efficiently delivering nucleic acids to cochlear and vestibular cells, and methods of treating sensory transduction disorders associated with a genetic defect. Some embodiments are directed to a synthetic inner ear hair cell targeting adeno-associated virus (AAV) vector, a cell comprising the synthetic inner ear hair cell targeting AAV vector, and method of treating Usher Syndrome in a subject using the synthetic inner ear hair cell targeting AAV vector.

Abstract: The invention features a prospective respiratory motion compensation technique for cardiovascular magnetic resonance imaging of the whole-heart of a free-breathing subject.

Abstract: Provided herein are 2?-O-methyl 3?phosphorothioate (MS)-modified synthetic nucleic acid molecules (single guide RNAs (sgRNAs)) for the use with a Cas9 nuclease in combination as a ribonucleoprotein (RNP) complex for an electroporation-based ex vivo targeted gene disruption of the BCL11A erythroid enhancer's +55, +58, or +62, functional regions. Additionally, provided herein are said RNP complexes (Cas9:MS-sgRNA), and compositions comprising the modified synthetic nucleic acid molecules or said RNP complexes, and methods for increasing fetal hemoglobin levels in a cell by disrupting BCL11A expression at the genomic level. Also provided herein are methods and compositions relating to the treatment of hemoglobinopathies by reinduction of fetal hemoglobin levels.